You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DRIO Conversion Disclosure
Raphael Erez · SEC Form 4 · Filed Sep 28, 2026
Conversion
Calculated transaction value
$30K
Raphael Erez Chief Executive Officer
DRIO
DarioHealth Corp
DRIO
Transaction date
Aug 12, 2024
Public filing date
Sep 28, 2026
Filing lag
Filed 777 days later
DRIO daily price context
Close on/before transaction
$19.1
Aug 12, 2024
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B-2 Preferred Stock on Common Stock
- Quantity / price
- 30 shares @ $1K
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-111343
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$41.06K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dariohealth Corp. DRIO | Award | Sep 24, 2026 | $0 |
| Dariohealth Corp. DRIO | Conversion | Aug 12, 2024 | $11.06K |
| Dariohealth Corp. DRIO Current | Conversion | Aug 12, 2024 | $30K |